Progress: Awaiting final decision
Role | Committee | Rapporteur | Shadows |
---|---|---|---|
Lead | LIBE | ŠKRIPEK Branislav ( ECR) | HORTEFEUX Brice ( PPE), HEDH Anna ( S&D), PAGAZAURTUNDÚA Maite ( ALDE) |
Lead committee dossier:
Events
The European Parliament adopted by 635 votes to 11, with 37 abstentions, following the consultation procedure, a legislative resolution on the draft Council implementing decision on subjecting the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenylN-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures.
Parliament approved the Council draft which aims to subject the new psychoactive substances cyclopropylfentanyl and methoxyacetylfentanyl to control measures and criminal penalties, as provided for under their legislation, in compliance with their obligations under the 1961 United Nations Single Convention on Narcotic Drugs as amended by the 1972 Protocol.
The Committee on Civil Liberties, Justice and Home Affairs adopted the report by Branislav ŠKRIPEK (ECR, SK) on the draft Council implementing decision on subjecting the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenylN-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures.
The committee recommended that Parliament approve the Council draft .
The risks of cyclopropylfentanyl and methoxyacetylfentanyl were assessed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and submitted to the Commission and to the Council on 23 March 2018.
The available evidence and information on the health and social risks that the substances pose, given also their similarities with fentanyl, provides sufficient ground for subjecting cyclopropylfentanyl and methoxyacetylfentanyl to control measures across the Union.
PURPOSE: to subject the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures.
PROPOSED ACT: Council Implementing Decision.
ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.
BACKGROUND: the risks of cyclopropylfentanyl and methoxyacetylfentanyl were assessed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and submitted to the Commission and to the Council on 23 March 2018.
They are both synthetic opioids and are structurally related to fentanyl, a controlled substance widely used in medicine as an adjunct to general anaesthesia during surgery and for pain management. The acute toxicity of cyclopropylfentanyl and methoxyacetylfentanyl are such that it can cause severe harms to the health of individuals.
Cyclopropylfentanyl has been available in the Union since at least June 2017 and has been detected in six Member States who reported 140 seizures in total between June 2017 and January 2018. 77 deaths have been reported by two Member States where exposure to cyclopropylfentanyl was confirmed.
Methoxyacetylfentanyl has been available in the Union since at least November 2016 and has been detected in eleven Member States who reported 44 seizures in total between June and December 2017. 13 deaths have been reported by four Member States where exposure to methoxyacetylfentanyl was confirmed.
Both cyclopropylfentanyl and methoxyacetylfentanyl appear to be sold online in small and wholesale amounts, under the guise of a "research chemical" or as "legal" replacement to illicit opioids, mainly as a powder or as a solution in ready-to-use nasal sprays.
The available evidence and information on the health and social risks that the substances pose, given also their similarities with fentanyl, provides sufficient ground for subjecting cyclopropylfentanyl and methoxyacetylfentanyl to control measures across the Union.
CONTENT: the draft Council implementing decision aims to subject the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide ('cyclopropylfentanyl') and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide ('methoxyacetylfentanyl') to control measures and criminal penalties, as provided for under their legislation, in compliance with their obligations under the 1961 United Nations Single Convention on Narcotic Drugs as amended by the 1972 Protocol.
PURPOSE: to subject the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) to control measures.
PROPOSED ACT: Council Implementing Decision.
ROLE OF THE EUROPEAN PARLIAMENT: the Council adopts the act after consulting the European Parliament but without being obliged to follow its opinion.
BACKGROUND: the risks of cyclopropylfentanyl and methoxyacetylfentanyl were assessed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and submitted to the Commission and to the Council on 23 March 2018.
They are both synthetic opioids and are structurally related to fentanyl, a controlled substance widely used in medicine as an adjunct to general anaesthesia during surgery and for pain management. The acute toxicity of cyclopropylfentanyl and methoxyacetylfentanyl are such that it can cause severe harms to the health of individuals.
Cyclopropylfentanyl has been available in the Union since at least June 2017 and has been detected in six Member States who reported 140 seizures in total between June 2017 and January 2018. 77 deaths have been reported by two Member States where exposure to cyclopropylfentanyl was confirmed.
Methoxyacetylfentanyl has been available in the Union since at least November 2016 and has been detected in eleven Member States who reported 44 seizures in total between June and December 2017. 13 deaths have been reported by four Member States where exposure to methoxyacetylfentanyl was confirmed.
Both cyclopropylfentanyl and methoxyacetylfentanyl appear to be sold online in small and wholesale amounts, under the guise of a "research chemical" or as "legal" replacement to illicit opioids, mainly as a powder or as a solution in ready-to-use nasal sprays.
The available evidence and information on the health and social risks that the substances pose, given also their similarities with fentanyl, provides sufficient ground for subjecting cyclopropylfentanyl and methoxyacetylfentanyl to control measures across the Union.
CONTENT: the draft Council decision aims to subject the new psychoactive substances cyclopropylfentanyl and methoxyacetylfentanyl) to control measures and criminal penalties, as provided for under their legislation, in compliance with their obligations under the 1961 United Nations Single Convention on Narcotic Drugs as amended by the 1972 Protocol.
Documents
- Results of vote in Parliament: Results of vote in Parliament
- Decision by Parliament: T8-0320/2018
- Committee report tabled for plenary, 1st reading/single reading: A8-0271/2018
- Committee draft report: PE623.813
- Legislative proposal published: 09420/2018
- Initial legislative proposal published: COM(2018)0253
- Initial legislative proposal published: EUR-Lex
- Committee draft report: PE623.813
Votes
A8-0271/2018 - Branislav Škripek - Vote unique 11/09/2018 12:43:06.000 #
History
(these mark the time of scraping, not the official date of the change)
procedure/Other legal basis |
Old
Rules of Procedure EP 159New
Rules of Procedure EP 165 |
procedure/Other legal basis |
Old
Rules of Procedure EP 159New
Rules of Procedure EP 165 |
docs/0 |
|
docs/1 |
|
events/0/date |
Old
2018-04-29T00:00:00New
2018-04-30T00:00:00 |
events/1/date |
Old
2018-06-10T00:00:00New
2018-06-11T00:00:00 |
committees/0/shadows/3 |
|
docs/0 |
|
docs/0 |
|
docs/1 |
|
docs/2 |
|
docs/2/docs/0/url |
https://www.europarl.europa.eu/doceo/document/LIBE-PR-623813_EN.html
|
events/0/date |
Old
2018-04-30T00:00:00New
2018-04-29T00:00:00 |
events/1/date |
Old
2018-06-11T00:00:00New
2018-06-10T00:00:00 |
events/2/body |
EP
|
events/3/body |
EP
|
events/6/body |
EP
|
docs/0/docs/0/url |
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE623.813
|
events/2 |
|
events/2 |
|
events/3 |
|
events/3 |
|
events/6 |
|
events/6 |
|
committees/0 |
|
committees/0 |
|
committees/0 |
|
committees/0 |
|
committees/0 |
|
committees/0 |
|
committees/0 |
|
committees/0 |
|
committees/0 |
|
committees/0 |
|
procedure/Modified legal basis |
Rules of Procedure EP 159
|
procedure/Other legal basis |
Rules of Procedure EP 159
|
docs/0/docs/0/url |
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE623.813New
https://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE623.813 |
events/4/docs/0/url |
Old
http://www.europarl.europa.eu/doceo/document/A-8-2018-0271_EN.htmlNew
https://www.europarl.europa.eu/doceo/document/A-8-2018-0271_EN.html |
events/6/docs/0/url |
Old
http://www.europarl.europa.eu/doceo/document/TA-8-2018-0320_EN.htmlNew
https://www.europarl.europa.eu/doceo/document/TA-8-2018-0320_EN.html |
events/4/docs/0/url |
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2018-0271&language=ENNew
http://www.europarl.europa.eu/doceo/document/A-8-2018-0271_EN.html |
events/6/docs/0/url |
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2018-0320New
http://www.europarl.europa.eu/doceo/document/TA-8-2018-0320_EN.html |
committees/0 |
|
committees/0 |
|
events/5 |
|
activities |
|
commission |
|
committees/0 |
|
committees/0 |
|
docs |
|
events |
|
links |
|
other |
|
procedure/Modified legal basis |
Old
Rules of Procedure EP 150New
Rules of Procedure EP 159 |
procedure/dossier_of_the_committee |
Old
LIBE/8/13013New
|
procedure/instrument |
Decision
|
procedure/stage_reached |
Old
Awaiting Parliament 1st reading / single reading / budget 1st stageNew
Awaiting final decision |
procedure/subject |
Old
New
|
activities/0/docs/0/text |
|
activities/0/docs/0/type |
Old
Legislative proposal publishedNew
Initial legislative proposal published |
activities/0/type |
Old
Legislative proposal publishedNew
Initial legislative proposal published |
activities/1 |
|
activities/2 |
|
activities/3 |
|
activities/4 |
|
activities/5 |
|
committees/0/date |
2018-06-20T00:00:00
|
committees/0/rapporteur |
|
committees/0/shadows |
|
procedure/Modified legal basis |
Rules of Procedure EP 150
|
procedure/dossier_of_the_committee |
LIBE/8/13013
|
procedure/stage_reached |
Old
Preparatory phase in ParliamentNew
Awaiting Parliament 1st reading / single reading / budget 1st stage |
activities |
|
committees |
|
links |
|
other |
|
procedure |
|